Erika Hamilton
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
Erika Hamilton
Sep 4, 2024, 14:06 |
Blog
Erika Hamilton: Happy to join the panel of FDA-ASCO
Erika Hamilton, Breast Executive Committee Director at Sarah Cannon Research Institute, shared a post on…
Aug 25, 2024, 13:09 |
Blog
Allison Zibelli and Erika Hamilton discussing data from the DESTINY-Breast06 and A-BRAVE trials
Sidney Kimmel Comprehensive Cancer Center at Jefferson shared a post on LinkedIn: "Dr. Allison Zibelli,…
Aug 7, 2024, 16:50 |
Blog
The recipients of the 2024 ESMO Society Awards
The 2024 ESMO Society Awards have been announced on 6th August by ESMO. ESMO recently…
Jul 31, 2024, 03:15 |
Blog
Erika Hamilton: Happy to get the word out about the VERITAC2 trial
Erika Hamilton posted on LinkedIn about a recent paper, titled "VERITAC-2: a Phase III study of…
Jul 27, 2024, 22:17 |
Insight
Commentary led by Marleen Kok highlights all questions in early TNBC post-KN522
Erika Hamilton shared on X: "This commentary led by Marleen Kok highlights all the pertinent…
Jul 26, 2024, 15:07 |
Blog
Erika Hamilton: Registration for Great Debates and Updates in Women's Oncology is now open
Erika Hamilton shared a post on LinkedIn: ''Are you registered for Great Debates and Updates…
Jul 26, 2024, 13:06 |
Blog
Register for the 13th Asia-Pacific Breast Cancer Summit in Singapore
13th Asia-Pacific Breast Cancer Summit 2025 shared a post on LinkedIn: "Please join us at…
Jul 26, 2024, 00:18 |
Blog
Erika Hamilton: Join us in Nashville for updates in Women's Oncology
Erika Hamilton shared on X: "Join us in Nashville for updates in Women's Oncology. BCSM…
Jul 19, 2024, 22:55 |
Blog
Potential of "smart warheads" in oncology - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared a post on LinkedIn: "Exciting developments in cancer treatment! Erika…
Jul 19, 2024, 08:35 |
Blog
Oncoinfluencers to Follow on Social Media: Dr. Erika Hamilton
As our next oncoinfluencer we are excited to feature Dr. Erika Hamilton, a prominent medical…
Jun 29, 2024, 09:05 |
Blog
Erika Hamilton: Always worth major celebration when we see survival improve by 10 months in metastatic cancer
Erika Hamilton shared a post by Healthbook on LinkedIn, adding: "Always worth major celebration when we…
Jun 28, 2024, 06:15 |
Blog
The American Journal of Managed Care highlights the latest research from Erika Hamilton
Sarah Cannon Research Institute shared the following post on LinkedIn: “AJMC - The American Journal…
Jun 24, 2024, 13:33 |
Blog
Erika Hamilton's insights into the future of ADCs in oncology - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared the following post on LinkedIn: “We are thrilled to share…
Jun 21, 2024, 14:07 |
Blog
Rahul Gosain: Breast Cancer Highlights from ASCO24 with Erika Hamilton
Rahul Gosain shared on LinkedIn: . "Breast Cancer…
Jun 10, 2024, 10:16 |
Societies
It is humbling to present trials that advance care for patients to our colleagues from across the world - SCRI Oncology Partners
SCRI Oncology Partners recently shared on LinkedIn: "SCRI Oncology Partners and Sarah Cannon Research Institute…
Jun 7, 2024, 09:11 |
Insight
Erika Hamilton: Happy to share the publication in Annals of Oncology
Erika Hamilton shared a post on X: “Happy to share the publication in Annals of…
Jun 7, 2024, 00:29 |
Societies
Erika Hamilton: I am leaving ASCO24 filled with renewed energy and inspiration
Erika Hamilton shared a post on LinkedIn: "ASCO24 did not disappoint! So appreciative of Lynn…
Jun 6, 2024, 14:33 |
Blog
Erika Hamilton: Thanks for fantastic ASCO24 leadership
Erika Hamilton shared on X/Twitter: "Thanks to Lynn Schuchter, Angie DeMichele, and Thomas LeBlanc for fantastic…
Jun 6, 2024, 00:26 |
Societies
Thomas LeBlanc: ASCO24, that's a wrap!
Thomas LeBlanc, Chief Patient Experience and Safety Officer at Duke Cancer Institute, shared on X: “ASCO24,…
Jun 5, 2024, 04:25 |
Blog
Giuseppe Curigliano: Excited to see NBC News highlight the groundbreaking results of DESTINY-06
Giuseppe Curigliano reposted Erika Hamilton's post on LinkedIn, adding: . "Excited to see NBC…
Jun 4, 2024, 16:28 |
Societies
Erika Hamilton: Data that pCR translates to outcome in TNBC
Erika Hamilton shared a post on X: “PEARLY: Adriamycin Cyclophosphamide (AC) to Taxane versus AC…
Jun 4, 2024, 03:22 |
Blog
Vivek Subbiah: Our amazing CSO Dr. Spigel will be presenting at the big plenary!
Vivek Subbiah shared on X/Twitter: "ASCO24 Sunday morning! Starting the day with Skip Burris, Conquer Cancer,…
Jun 2, 2024, 20:40 |
Blog
Erika Hamilton: Skip Burris has been the best mentor and champion for me
Erika Hamilton shared on X/Twitter: "My favorite picture so far at ASCO24. Have to love Skip…
Jun 2, 2024, 09:09 |
Societies
15 Posts From ASCO24 Day 2 You Should Not Miss!
The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting is being held from May…
Jun 2, 2024, 08:53 |
Blog
Erika Hamilton: Lynn Schuchter emphasizes how important communication is in oncology care
Erika Hamilton shared on LinkedIn: "ASCO president Lynn Schuchter emphasizes how important communication is in…
May 29, 2024, 22:44 |
Blog
Vivek Subbiah: Prepping to ASCO24 - Super Bowl for oncology
Vivek Subbiah shared on LinkedIn: "Countdown to ASCO24 Annual meeting is on! Excited for the biggest cancer…
May 26, 2024, 08:16 |
Blog
Kamal S. Saini: Enrollment is Ongoing for Phase 3 study CAMBRIA-1
Kamal S. Saini, Executive Medical Director and Head of European Medical Oncology Team at Fortrea…
May 25, 2024, 09:42 |
Societies
SCRI Oncology Partners introduces its members
Sarah Cannon Research Centre (SCRI) Oncology Partners shared on LinkedIn: With our new LinkedIn page, we…
May 21, 2024, 10:00 |
Blog
Erika Hamilton: Thanks to all who attended ESMO Breast24 and made it such a success
Erika Hamilton shared a post on LinkedIn: ''Thanks to all who attended ESMO Breast24 and…
May 19, 2024, 14:11 |
Societies
20 Posts Not To Miss From ESMOBreast24!
ESMO Breast Cancer 2024 (ESMOBreast24) took place as an onsite and online event in Berlin,…
May 18, 2024, 11:16 |
Blog
Paolo Tarantino: Important point by Erika Hamilton - common questions should derive from RCTs
Paolo Tarantino shared the following post by ESMO on X, adding the following: "Important point…
May 18, 2024, 04:23 |
Blog
Kevin Punie: ESMO Ambassadors great overview by Erika Hamilton on emerging ADC targets
Kevin Punie, Medical Oncologist at GZA Hospitals Sint-Augustinus, shared a post on X/Twitter: ''Great overview…
May 17, 2024, 14:50 |
Insight
Erika Hamilton: Rupert Bartsch delivers a sobering reminder on brain metastasis
Erika Hamilton shared a post on X: “Rupert Bartsch delivers a sobering reminder: Although we can…
May 16, 2024, 10:02 |
Blog
Updated Breast Cancer Screening Recommendation - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared on LinkedIn: "Updated Breast Cancer Screening Recommendation. SCRI breast cancer…
May 14, 2024, 03:07 |
Blog
Erika Hamilton: Fantastic list for ESMO Breast 24
Erika Hamilton shared a post by Paolo Tarantino on LinkedIn, adding: "Fantastic list for ESMO Breast 24.…
May 13, 2024, 12:54 |
Blog
Become part of the conversation about the science presented at ESMO Breast24
European Society for Medical Oncology shared on their X page: "Do not miss the latest…
May 13, 2024, 07:59 |
Blog
Erika Hamilton: Check out our new practice LinkedIn page
Erika Hamilton shared a post by SCRI Oncology Partners on LinkedIn, adding: ''Check out our new practice…
May 9, 2024, 11:35 |
Insight
Vivek Subbiah: SERENA-1 monotherapy results in Annals of Oncology
Quoting Vivek Subbiah on X: . "A Phase 1 dose escalation and expansion trial of…
May 8, 2024, 10:41 |
Blog
Erika Hamilton: An update from the previous 2016 guideline and a couple highlights
Erika Hamilton shared a post on LinkedIn: "Thanks to News Nation and Nichole Berlie for having…
May 5, 2024, 00:31 |
Blog
Erika Hamilton: Thanks for having me on USPTF updated breast screening recommendations
Erika Hamilton shared on LinkedIn: “Thanks to News Nation and Nichole Berlie for having me…
Apr 29, 2024, 20:00 |
Opinion
Erika Hamilton: Really feel like we don't need to be testing for HER-2 for TDXd in breast cancer
Erika Hamilton shared a post by Giuseppe Curigliano, Chief of the Clinical Division of Early…
Apr 27, 2024, 15:34 |
Insight
Erika Hamilton: Happy to share our publication re: T-DXd vs. T-DM1 among patients with brain metastasis in DB-03
Erika Hamilton shared on LinkedIn: "Happy to share our publication re: T-DXd vs. T-DM1 among…
Apr 23, 2024, 16:35 |
Blog
Stephanie Graff: Sheila Johnson is a force—I hope to carry her energy and spirit in all that I do
Stephanie Graff shared a post by Erika Hamilton on X and added: "Sheila Johnson is…
Apr 9, 2024, 16:59 |
Positive
Erika Hamilton: This is the power of clinical trials!
Erika Hamilton shared a post by Mel Mann, a Patient Advocate for Oncology, Health Equity,…
Apr 4, 2024, 13:03 |
Blog
Erika Hamilton: Join us for The Future on Breast Cancer Conference East
Erika Hamilton shared on LinkedIn "Need CME for breast cancer? Join us for The Future…
Mar 22, 2024, 05:34 |
Societies
Tian Zhang: ASCO Record setting about 7000 abstracts this year
Tian Zhang, Associate Professor in the Department of Internal Medicine at UT Southwestern Medical Center,…
Mar 22, 2024, 05:19 |
Blog
Erika Hamilton: 100 cycles on a phase I clinical trial for metastatic disease - THIS is why we do clinical trials
Erika Hamilton and Vivek Subbiah shared a post by Sarah Cannon Research Institute: "Several years ago,…
Mar 22, 2024, 01:30 |
Blog
Theresa celebrated 100 months on her phase 1 clinical trial - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared the following post on LinkedIn: "Several years ago, Theresa noticed…
Mar 14, 2024, 19:28 |
Drugs
François-Clément Bidard: A prospective study to document the efficacy of the combo Fulvestrant+Everolimus
Erika Hamilton, Director of Breast Cancer and Gynecologic Cancer Research at Sarah Cannon Research Institute, shared…
Feb 27, 2024, 15:23 |
Blog
Paolo Tarantino: Great JSMO24 session on HR+ MBC
Paolo Tarantino, Clinical Research Fellow at Dana-Farber Cancer Institute, recently posted on X/Twitter: "Great JSMO24…
Feb 26, 2024, 19:24 |
Blog
Paolo Tarantino: True honour to have the opportunity of joining the outstanding faculty of JSMO24 to review
Paolo Tarantino, Medical Oncologist and Research Fellow at Dana-Farber Cancer Institute, shared a post by…
Feb 26, 2024, 19:20 |
Blog
Erika Hamilton: Otto Metzger discusses molecular biomarkers and how we may use in HR+ bcsm
Erika Hamilton shared on X/Twitter: “Otto Metzger discusses molecular biomarkers and how we may use in…
Feb 25, 2024, 23:51 |
Blog
Erika Hamilton: JSMO24 has really been one of the best experiences EVER at a conference
Erika Hamilton, Chair of Executive Committee Breast and Breast Program lead at Sarah Cannon Research…
Jan 30, 2024, 16:31 |
Insight
Erika Hamilton: This is what drove the recommendations for colonoscopy to start at 45, not 50 like it used to be
Erika Hamilton recently shared a post by Samu Shiva, Physician Lead of Lifestyle Medicine and…
Jan 29, 2024, 14:31 |
Blog
Erika Hamilton: An update in high risk HR+ bcsm
Erika Hamilton shared a post on LinkedIn: “Need a little bit of CME or want…
Jan 16, 2024, 17:09 |
Blog
Erika Hamilton: Proud of the message Sara Sidner shared on CNN
Erika Hamilton shared a post by Sarah Cannon Research Institute on LinkedIn: "When public figures share…
Jan 14, 2024, 17:39 |
Insight
Erika Hamilton: Happy to share publication on updated monarchE data with adjuvant abemaciclib
Erika Hamilton , Chair of Executive Committee Breast and Breast Program lead at Sarah Cannon…
Jan 7, 2024, 15:14 |
Drugs
Paolo Tarantino: Decades of cancer research converging on new effective treatment options for our patients with HR-positive breast cancer
Paolo Tarantino, Medical Oncologist and Research Fellow at the Dana-Farber Cancer Institute, shared on LinkedIn:…
Jan 1, 2024, 16:35 |
Blog
Erika Hamilton: Happy to have partnered with OBR to help get the word out about the new recommendations for germline testing in bcsm
Erika Hamilton shared a post on LinkedIn: "Happy to have partnered with OBR to help get…
Dec 22, 2023, 13:39 |
Blog
Erika Hamilton: Algorithms and pathways can help us make sure patients aren't missed for testing
Erika Hamilton shared a post by Jame Abraham, Chairman of the Department of Hematology and…
Dec 11, 2023, 11:15 |
Blog
Vivek Subbiah: Precision Medicine - This is how we eradicate cancer as we know it
Vivek Subbiah shared on X/Twitter: "The best breast cancer clinical trial research strategy team in…
Nov 17, 2023, 16:53 |
Opinion
Erika Hamilton: I don't think it's appropriate to not tell patients...
Erika Hamilton shared a post by Mark Lewis on X/Twitter, adding: "Agree. It's not our…
Nov 15, 2023, 18:11 |
Blog
Erika Hamilton: The colour of your skin or your zip code shouldn't be a determinant to whether you get good oncology care
Erika Hamilton shared a post by Arif Kamal on LinkedIn: "I have loved partnering with…
Nov 10, 2023, 23:38 |
Blog
Rahul Gosain: ESMO23 Breast Cancer Highlights with Erika Hamilton
Rahul Gosain, Medical Director & Director of Regional Infusion Services, made the following post on…
Oct 24, 2023, 15:16 |
Blog
Erika Hamilton: Often times when people consider the hardship or "cost" of cancer and chemotherapy, these things are forgotten
Erika Hamilton shared on LinkedIn: "This is huge. Often times when people consider the hardship…
Oct 23, 2023, 15:40 |
Blog
Erika Hamilton: Not all AEs are equal...
Erika Hamilton shared a post by Hope Rugo on X/Twitter: “Not all AEs are equal…
Oct 12, 2023, 20:57 |
Insight
Erika Hamilton: Excited to see further updates from monarchE at ESMO23.
Erika Hamilton, made the following post on LinkedIn: "Excited to see further updates from monarchE…
Oct 5, 2023, 21:12 |
Blog
Erika Hamilton: This October for Breast Cancer Awareness month, let's remember that awareness goes beyond prevention alone.
Erika Hamilton, made the following post on LinkedIn: "This October for Breast Cancer Awareness month, let's…
Oct 3, 2023, 17:02 |
Blog
,
Opinion
Stacey Tinianov: If you feel compelled to show your support in this breast cancer awareness month, please consider the following...
Erika Hamilton, Chair of Breast Executive Committee and Breast Program lead for Sarah Cannon Research…
Sep 25, 2023, 15:11 |
Blog
Erika Hamilton: ASCO Plenary Series allows you the opportunity to present your data globally within 2 months of submission!
Erika Hamilton, shared the following on LinkedIn: "ASCO Plenary Series allows you the opportunity to…
Sep 24, 2023, 18:45 |
Blog
Erika Hamilton: The advances we make every year to improve cancer outcomes are due to clinical trials.
Erika Hamilton shared on LinkedIn: “Today is World Cancer Research Day. Clinical trials couldn't be…
Sep 16, 2023, 19:08 |
Blog
Erika Hamilton: Fantastic time this week rolling up our sleeves at ASCO headquarters working on ASCO24 education program.
Erika Hamilton, Chair, Executive Committee Breast and Breast Program Lead at Sarah Cannon Research Institute,…
Sep 16, 2023, 18:50 |
Positive
100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023: Part 4
Three weeks ago, OncoDaily initiated its series on '100 Influential Women in Oncology: Key Opinion…
Sep 13, 2023, 13:50 |
Blog
Erika Hamilton: ESMO Breast Cancer 2024 abstract submission system is NOW OPEN!
Erika Hamilton, Medical Oncologist, Director of Breast Cancer Research Program at Sarah Cannon Research Institute,…
Sep 8, 2023, 19:01 |
Blog
,
Insight
Erika Hamilton: Can't be more clear than these commitments from American Cancer Society National Breast Cancer Roundtable 2023 today.
Quoting Erika Hamilton, the Director of Breast Cancer Research Program at Sarah Cannon Research Institute,…
Sep 5, 2023, 16:59 |
Blog
,
Insight
,
Opinion
Breast Cancer in Younger Women: Rethinking Age-Based Screenings Amid Rising Rates.
OncoDaily Editorial Staff The persistent myth that breast cancer is a disease affecting primarily older…
May 25, 2023, 11:56 |
Societies
One of our group's recommendations was to make a version of this available to ALL ASCO members - Erika Hamilton
As part of American Society of Clinical Oncology (ASCO) Leadership Development Program, we all received…
All:
77
Posts:
1 - 100
Immunotherapy vs Chemotherapy: Success Rates, Side Effects, Costs Compared
Small Bowel Cancer: Symptoms & Causes, Types, Diagnosis and Treatment
Mikkael A. Sekeres, Candidate for Secretary of ASH
Paolo Tarantino: Top 10 Breast Cancer abstracts from ESMO2024
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 2
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube